Vimarsana
Biggest News Aggregation in the World

Functional Epigenetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional Epigenetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Epigenetics Today - Breaking & Trending Today

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells - Vimarsana News

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

Tiragolumab, an anti-TIGIT antibody with an active IgG1κ Fc, demonstrated improved outcomes in the phase 2 CITYSCAPE trial (ClinicalTrials.gov: NCT03563716 ) when combined with atezolizumab (anti-PD-L1) versus atezolizumab alone1. However, there remains little consensus on the mechanism(s) of response with this combination2. Here we find that a high baseline of intratumoural macrophages and regulatory T cells is associated with better outcomes in patients treated with atezolizumab plus tiragolumab but not with atezolizumab alone. Serum sample analysis revealed that macrophage activation i...

Source: nature.com
New blood test could make preeclampsia easier to predict, early study suggests - Vimarsana News

New blood test could make preeclampsia easier to predict, early study suggests

A blood test looks at "chemical tags" on top of DNA to predict how likely a person is to develop preeclampsia.